FMP
Dec 23, 2024 7:17 PM - Davit Kirakosyan(Last modified: Dec 24, 2024 1:15 AM)
Image credit: FMP
Brookline Capital Markets analysts initiated coverage of Exelixis (NASDAQ:EXEL) with a Buy rating, highlighting the biotech company’s strong commercial presence and growth potential across its drug portfolio and pipeline. The firm sees significant upside, projecting Exelixis could reach a valuation of $40 per share within the next 12 to 18 months.
Exelixis, a commercial-stage biotechnology company, is expected to continue expanding its key therapies, Cabometyx and Cometriq, while its partner Genentech advances Cotellic. The company’s robust early-stage pipeline also holds potential for future growth. The analysts estimate that Exelixis’ total revenue could grow at a compound annual growth rate (CAGR) of 15% over the next 7 to 10 years, reaching $7.1 billion by 2033.
Key drivers of this growth include additional indications for Cabometyx and the anticipated commercialization of a new pipeline product within the coming years. The analysts expect total product sales to grow to $6.7 billion by 2033, assuming successful execution. However, as with all development-stage biotech companies, these estimates carry inherent risks related to clinical development and market adoption.
May 14, 2024 11:41 AM - Sanzhi Kobzhan
A stock's target price, also known as its fair value, is an indication of what a share can cost based on the company’s forecasted financial statements. It is important to know a stock's fair value to find undervalued stocks with great growth potential. Let's consider how investment analysts calculat...
May 24, 2024 9:30 AM - Rajnish Katharotiya
Earnings call transcripts are invaluable resources for investors, analysts, and financial enthusiasts. They provide insights into a company's performance, strategy, and future outlook, making them essential for making informed investment decisions. With Financial Modeling Prep, Earnings Call Transcr...
May 27, 2024 3:30 PM - Rajnish Katharotiya
In the ever-evolving world of technology, certain sectors have consistently demonstrated exceptional growth and innovation. The graphics processing units (GPUs) industry is one such sector, offering investors a golden opportunity for potentially high returns. In this blog, we'll delve into why inves...